| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 10/06/2004 | CN1535146A 5-halo-tryptamine derivatives used as ligands of 5-HT 6 and/or 5-HT7 serotonin receptors |
| 10/06/2004 | CN1535139A Atorvastatin hemi-calcium form VII |
| 10/06/2004 | CN1534035A Water soluble thalidomide derivrative |
| 10/06/2004 | CN1534017A N-(2-phenyl-4-amino-batyl)-1-naphthol carboxy amide kind compound used as neuropeptide-1-acceptor antagonistic agent |
| 10/06/2004 | CN1533806A Liver cell growing promotor injection and its preparation method and application |
| 10/06/2004 | CN1533805A Capsule formula for treating astriction prepared using pumpkin as main raw material and its preparation method |
| 10/06/2004 | CN1533803A Swim bladder marrow growing capsule |
| 10/06/2004 | CN1533801A Golden hairpin dendrobium extract and its medicinal composition |
| 10/06/2004 | CN1533796A Chinese medicine for treating chronic gastratrophia and its preparation process |
| 10/06/2004 | CN1533795A Chinese medicine for treating digestive ulcerating sore and its preparation method |
| 10/06/2004 | CN1533790A Chinese medicine can |
| 10/06/2004 | CN1533788A Medicine for treating virus diarrhea and its preparation method |
| 10/06/2004 | CN1533787A Compound preparation for treating child diarrhea and its preparation method |
| 10/06/2004 | CN1533785A Medicine for treating diarrhea and its preparation method |
| 10/06/2004 | CN1533783A Gastrelcoma plaster |
| 10/06/2004 | CN1533780A Crocodile fetus element |
| 10/06/2004 | CN1533708A Injure preventing agent for forcedly changing feather and method for forcedly changing feather |
| 10/06/2004 | CN1169938C Chinese herbal medicine long life wine |
| 10/06/2004 | CN1169826C Magnesium isoplycyrrhetate and its preparing process and usage |
| 10/06/2004 | CN1169825C Process for extracting triterpenic acid from gleditschia, and medical use and chinese medicine of triterpenic acid |
| 10/06/2004 | CN1169808C 'Beta'-carboline compound |
| 10/06/2004 | CN1169793C Process for producing bis (4-amino-1-pyridine) paraffins |
| 10/06/2004 | CN1169789C Aminoalkoxy carbazoles for treatment of CNS diseases |
| 10/06/2004 | CN1169570C Medicine for treating acute and chronic hepatitis B |
| 10/06/2004 | CN1169565C Medicine for treating throat disease and stomatopathy |
| 10/06/2004 | CN1169561C Medicine for treating diseases of rectum and anus, peptic ulcer and mastosis and producing process |
| 10/06/2004 | CN1169555C Decocted pill medicine for treating excess syndrome of hepatitis B |
| 10/06/2004 | CN1169554C Traditional Chinese medicine for curing gastroptosis and gastric ulcer |
| 10/06/2004 | CN1169539C Forestfrog oil tonic tablet |
| 10/06/2004 | CN1169535C Chinese medicine for treating hepatitis B |
| 10/06/2004 | CN1169527C Methods of modulating serine-threnoine protein kinase function with 5-azaquinoxaline-based compounds |
| 10/06/2004 | CN1169522C Controlled release bead, of producing the same and multiple unit formulation comprising it |
| 10/06/2004 | CN1169516C Oral cleaning detergent component and tooth-paste, tooth powder component |
| 10/05/2004 | US6800650 For therapy and prophylaxis of diabetes, particularly non-insulin dependent diabetes mellitus and impaired glucose tolerance. |
| 10/05/2004 | US6800639 Dioxolane nucleosides and nucleoside analogues such as troxacitabine together with chemotherapeutic agents other than doxorubicin such as cytarabine, gemcitabine and idarubicin; synergistic mixture; treating leukemia, cancer |
| 10/05/2004 | US6800633 Pyrrolo[2,3d]pyrimidine compositions and their use |
| 10/05/2004 | US6800628 Such as (1-(2-((3-methyl-2-pyrazinyl)amino)ethyl)-4-piperidinyl)-methyl-4-amino-5 -chloro-2,3-dihydro-7-benzofurancarboxylate |
| 10/05/2004 | US6800627 Central nervous system, cardiovascular and gastrointestinal disorders, diabetes inspidus, sleep apnea |
| 10/05/2004 | US6800626 For therapy and prophylaxis of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, neurodegenerative diseases, allergies, reperfusion/ischemia in stroke, heart attacks, etc. |
| 10/05/2004 | US6800620 Contacting leukocytes, osteoclasts with an enzyme inhibitors, a 9h-purin-3h-quinazolin-4-one derivatives, treating bone-resorption disorder, antiproliferative agents treating leukemia cells |
| 10/05/2004 | US6800619 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives |
| 10/05/2004 | US6800613 Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds |
| 10/05/2004 | US6800446 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 10/05/2004 | US6800434 Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 10/05/2004 | US6800304 Anti-ulcer pharmaceutical composition and the preparation thereof |
| 10/05/2004 | CA2338480C Oral liquid mucoadhesive compositions |
| 10/05/2004 | CA2309439C 3-(3-hydroxyphenyl)-3-amino-propionamide derivatives |
| 10/05/2004 | CA2282834C Novel hexanoic acid derivatives |
| 10/05/2004 | CA2128956C Tricyclic diazepine vasopressin antagonists |
| 09/30/2004 | WO2004083425A1 Remedy for periodontal disease |
| 09/30/2004 | WO2004083200A1 Crystalline form of (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole |
| 09/30/2004 | WO2004083184A1 Receptor antagonist |
| 09/30/2004 | WO2004082715A1 Concomitant drug as therapeutic agent for inflammatory bowel disease |
| 09/30/2004 | WO2004082692A1 Actacid composition |
| 09/30/2004 | WO2004082690A1 Regulation of cell surface proteins |
| 09/30/2004 | WO2004082669A2 Antiflatulents in combibation with histamine h1-receptor antagonist for treating gastrointestinal disoders |
| 09/30/2004 | WO2004082665A1 Controlled release composition |
| 09/30/2004 | WO2004082574A2 Diagnostics and therapeutics for diseases associated with dopamine receptor d5 (drd5) |
| 09/30/2004 | WO2004082573A2 Diagnostics and therapeutics for diseases associated with dopamine receptor d4 (drd4) |
| 09/30/2004 | WO2004082567A2 Diagnostics and therapeutics for diseases associated with dopamine receptor d1a (drd1) |
| 09/30/2004 | WO2004058138A3 Oil composition based on peroxidised lipids, which can be used in the treatment of xerostomia |
| 09/30/2004 | WO2004038405A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43) |
| 09/30/2004 | WO2003106629A3 Treating vitamin d responsive diseases |
| 09/30/2004 | WO2003097806A3 Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/30/2004 | WO2003080105A9 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof |
| 09/30/2004 | WO2003068197A8 Method for systemic drug delivery through the nail |
| 09/30/2004 | US20040194159 Cloning pigs using donor nuclei from differentiated cells |
| 09/30/2004 | US20040192961 such as 2-nitrophenol by reacting 3-hydroxy-4-methoxybenzophenone with alkyl nitrate in presence of regioselective acid catalyst (sulfuric acid) |
| 09/30/2004 | US20040192943 Nf-kappab inhibitors |
| 09/30/2004 | US20040192916 Analgesics; neuropathic pain; headaches; muscle relaxants; incontence; tinnitus; diarrhea; antiarrhythmia agents; antiischemic agents; antiinflammatory agents; antiulcer agents; antidepressants; antiepileptic agents |
| 09/30/2004 | US20040192782 Erucamide compounds for the treatment and prevention to disturbances of the secretory system |
| 09/30/2004 | US20040192751 Amino acid composition for ameliorating liver failure |
| 09/30/2004 | US20040192742 Antiarthritic agents; muscular dystrophy; antiinflammatory agents; glomerulonephritis; malaria; oral diseases |
| 09/30/2004 | US20040192736 New indoline compounds |
| 09/30/2004 | US20040192733 Hydroxamic acid derivatives |
| 09/30/2004 | US20040192720 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| 09/30/2004 | US20040192716 Mixture with 2-amino-1,3-propanediol and excipients; synergistic mixture; concurrent administering |
| 09/30/2004 | US20040192701 Phenlypyridine carbonyl piperazine derivative |
| 09/30/2004 | US20040192694 Use of COX-2 inhibitors as gastroprokinetics |
| 09/30/2004 | US20040192689 Heterocycle-carboxamide derivatives as raf kinase inhibitors |
| 09/30/2004 | US20040192673 Obesity, non-insulin-dependent diabetes,strokes, sleep disorders; antiischemic and antiemetic agents |
| 09/30/2004 | US20040192667 Novel pyrazole analogs acting on cannabinoid receptors |
| 09/30/2004 | US20040191901 Insulin producing cells derived from human embryonic stem cells |
| 09/30/2004 | US20040191767 Comprises nucleotide sequences coding hepatitis core protein fusion for generating vaccine to prevent infcetion and treat liver dysfunction; gene therapy and cell-mediated immune response |
| 09/30/2004 | US20040191756 Transgenic rodent for diagnosing and identifying modulator for treatment and prevention inflammatory disorders |
| 09/30/2004 | US20040191295 Preventing rotavirus induced diarrhea; lactulose |
| 09/30/2004 | US20040191239 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 09/30/2004 | US20040191236 Administering antigen associated with disease, a dendritic cell binding agent specific for the antigen, and an autologous dendritic cell; immunotherapy |
| 09/30/2004 | US20040191219 HSA-free formulations of interferon-beta |
| 09/30/2004 | US20040191211 Tissue-specific transporter inhibitor |
| 09/30/2004 | US20040191210 Compounds |
| 09/30/2004 | CA2519439A1 Compositions and methods for treating colic |
| 09/30/2004 | CA2519208A1 Controlled release composition |
| 09/30/2004 | CA2517186A1 Regulation of cell surface proteins |
| 09/29/2004 | EP1462457A1 Cytotoxic protein and utilization thereof |
| 09/29/2004 | EP1462450A1 Substituted morpholine derivatives and their use as therapeutic agents |
| 09/29/2004 | EP1462449A1 Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha levels |
| 09/29/2004 | EP1462108A1 Interferon g (g) production promoter |
| 09/29/2004 | EP1462104A1 Optically pure (-) norcisapride for treating digestive tract disorders |
| 09/29/2004 | EP1461614A2 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs3 upregulation |